On August 23, 2022, Viracta Therapeutics, Inc. announced Michael Huang notified the Company of his resignation as a member of the Board of Directors of the Company and from all committees of the Board on which he served, effective as of August 23, 2022. Mr. Huang's resignation is not the result of any disagreement with the Company relating to the Company's operations, policies or practices.